Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 108 of the 118 references it cites were found in a registry or an index; 11 of the 21 sources its claims cite were checked for support.

Artificial Intelligence in the Diagnosis and Treatment of Pancreatic Cystic Lesions and Adenocarcinoma

Open access

Abstract

Review of AI applications to pancreatic cystic lesions and adenocarcinoma.

Overview

CoChat Summary

## TL;DR

This review surveys published AI/ML work on pancreatic cancer screening, pancreatic cystic lesion (PCL) risk stratification, treatment response, and prognosis, emphasizing studies from 2013–2023. Overall, the paper concludes that AI performs best for PCL classification and risk stratification, while screening models for predicting who will develop PDAC are less reliable.

## Key findings

  • In screening-oriented models, performance was modest: the review notes that existing AI models for the general population had AUCs “hovering around 0.60,” while a primary-care logistic regression model achieved AUCs of 65.6% for patients under 60 and 60.9% for older patients, and was estimated to enable earlier diagnosis for around 60% of pancreatic tumors.
  • For PCL detection/risk stratification, several models performed strongly: a radiomics random forest model in 214 resected cyst patients reached AUC 0.940 for distinguishing five cystic neoplasm types, compared with AUC 0.895 for academic radiologists; a fused radiomics–DL model reached AUC 0.92 for serous cystadenoma diagnosis and 0.97 for differentiating MCNs from IPMNs.
  • EUS-based AI also showed high accuracy: a CNN using 28 EUS cysts achieved AUC 1.0 for identifying mucinous cysts, with overall accuracy 98.5%, sensitivity 98.3%, and specificity 98.9%; another CNN using 43 patients with histologically proven IPMN classified advanced neoplasia with 99.6% accuracy, exceeding guideline accuracies of 51.8%–70.3% in that cohort.
  • For prognostication and treatment-related prediction, performance was promising but more variable: a random forest model predicted 2-year overall survival with AUC 0.76 and 1-year recurrence-free survival with AUC 0.74; another model reported AUC 90% with 87% sensitivity and 80% specificity for above- vs below-median survival.

## Methods

  • The paper is a narrative review of primary literature on novel AI algorithms for PDAC and precancerous pancreatic lesions.
  • The authors searched PubMed and Embase for combinations of “artificial intelligence,” “machine learning,” “radiomics,” or “deep learning” with “PDAC,” “pancreatic cystic lesions,” or “endoscopic ultrasound.”
  • Included studies were published from 2013–2023 and had to report accuracy-type metrics such as AUC, accuracy, sensitivity, or specificity; case reports, protocols, meta-analyses, and review articles were excluded.

## Limitations

  • The paper states that many imaging-based AI studies are retrospective, single-center, and not externally validated, which limits generalizability and reproducibility.
  • It also states that models may be biased toward higher-risk patients because histopathology from surgical resection is the reference standard, so included cohorts often consist of people who already required surgery.
  • The text makes evident that several cited studies had small sample sizes and manual preprocessing requirements; these are stated in the paper as limitations that reduce scalability and may contribute to overfitting.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/cancers15092410

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Precancerous lesions of the pancreas. Mucinous cysts: IPMNs and mucinous neoplasms (MCN). Non-mucinous cysts: serous pseudopapillary neoplasms (SPN), lymphoepithelial cysts (LEC), and cystic neuroendocrine tumors (NET). Pseudocysts, serous cystadenomas, and LEC are benign lesions.
Figure 1 Precancerous lesions of the pancreas. Mucinous cysts: IPMNs and mucinous neoplasms (MCN). Non-mucinous cysts: serous pseudopapillary neoplasms (SPN), lymphoepithelial cysts (LEC), and cystic neuroendocrine tumors (NET). Pseudocysts, serous cystadenomas, and LEC are benign lesions.CC BY · PubMed Central
Figure 2 AI developments in PDAC diagnosis and treatment. Machine learning has been leveraged to identify high-risk populations for PDAC screening, risk-stratify incidentally discovered PCLs, and assist with PDAC prognostication.
Figure 2 AI developments in PDAC diagnosis and treatment. Machine learning has been leveraged to identify high-risk populations for PDAC screening, risk-stratify incidentally discovered PCLs, and assist with PDAC prognostication.CC BY · PubMed Central

Verification

Claims the paper makes

8 Valid · 0 Not valid · 7 Not checked · 20 Own results and interpretations

5 more claims

Create a free account to see all 35 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 17
  • Probably not a substantial claim. 12

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 118 references

Research works printed but not linked: 1

  1. Moulin, 2022, [Diabetes and pancreatic cancer—When diabetes indicates a pancreatic cancer], Rev. Med. Suisse, 18, 1994

Cited by

See all 39

Metadata

Authors
Jiang, J., Chao, W.-L., Culp, S., & Krishna, S. G.
Affiliations
  • The Ohio State University Wexner Medical Center (US)
  • The Ohio State University (US)
Corresponding author
Krishna, Somashekar G.
Venue
Cancers
Publisher
MDPI AG
Published
2023-04-22
Volume
15
Issue
9
Pages
2410
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4366975505
Cited by
38
References
118
Citations by year
2026: 9 · 2025: 12 · 2024: 14 · 2023: 3
FWCI
0.80
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
National Cancer Institute (R01CA279965)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
Keywords
artificial intelligence, pancreatic cysts, pancreatic ductal adenocarcinoma, pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, pancreatic cancer screening, risk stratification, premalignant pancreatic lesions, endoscopic ultrasound-guided fine-needle aspiration, cyst fluid analysis, outcome prediction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Artificial Intelligence in the Diagnosis and Treatment of Pancreatic Cystic Lesions and Adenocarcinoma. https://app.cochat.ai/papers/10.3390/cancers15092410
The paper
Jiang, J., Chao, W.-L., Culp, S., & Krishna, S. G. (2023). Artificial Intelligence in the Diagnosis and Treatment of Pancreatic Cystic Lesions and Adenocarcinoma. Cancers. https://doi.org/10.3390/cancers15092410

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.